Healthcare CMO Market, By Service Type (Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients Manufacturing, Final Dosage Form Manufacturing Packaging) and Medical Device Contract Manufacturing Services ), By Geography

Description

Global healthcare CMO market is estimated to be valued at USD 171.10 Bn in 2024 and is expected to reach USD 447.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 171.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	14.70%	2031 Value Projection:	US$ 447.11 Bn

Figure. Healthcare CMO Market Share (%), By Region 2024

Global healthcare CMO market growth is driven by rising demand for high-quality pharmaceutical products across the world. Various pharmaceutical and biotechnology companies are increasingly outsourcing their manufacturing operations to contract manufacturing organizations, in order to focus on their core competencies of research and development, marketing and sales. The CMOs provide end-to-end manufacturing services right from drug development, clinical trial supplies, commercial manufacturing, packaging and regulatory support. This enables the biopharmaceutical players to reduce manufacturing costs and comply with stringent regulatory norms in a time-efficient manner.

Market Dynamics:

Global healthcare CMO market growth is driven by factors such as rising generic and biosimilar drugs market, growing demand for cost-effective pharmaceutical manufacturing outsourcing solutions, and increasing R&D investment in drug development. However, complexity in developing biological drugs, lack of skilled workforce and stringent regulations for manufacturing facilities can hamper the market growth. The companies in this market have opportunity to tap the emerging markets in Asia Pacific and Latin America, owing to availability of low-cost manufacturing base and skilled labor. Key market players are investing heavily in capacity expansion, advanced technologies and regulatory capabilities to strengthen their service portfolio and global footprint.

Key Features of the Study:

This report provides in-depth analysis of the global healthcare CMO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global healthcare CMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Catalent Inc., Recipharm AB, Aurobindo Pharma Limited, Jubilant Life Sciences Ltd., Boehringer Ingelheim GmbH, Lonza Group, and Patheon Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market

Detailed Segmentation-

By Service Type
- Pharmaceutical Contract Manufacturing Services
- Active Pharmaceutical Ingredients (API) Manufacturing
- Final Dosage Form (FDF) Manufacturing Packaging
- Medical Device Contract Manufacturing Services
- Outsourcing Design
- Device Manufacturing
- Material Process Services
- Electronic Manufacturing Services
- Finished Products
- Final Goods Assembly
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Lonza Group
- Catalent, Inc.
- Thermo Fisher Scientific (Patheon)
- Recipharm AB
- Siegfried Holding AG
- Aenova Group
- Almac Group
- Piramal Pharma Solutions
- Evonik Industries AG
- Famar Health Care Services
- Boehringer Ingelheim
- Consort Medical plc
- Pfizer CentreOne
- Baxter BioPharma Solutions
- Jubilant HollisterStier
- Vetter Pharma International GmbH
- Ajinomoto Bio-Pharma Services
- Fareva Group

Product Code: CMI4622

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Healthcare CMO Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Healthcare CMO Market, By Service Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Pharmaceutical Contract Manufacturing Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Active Pharmaceutical Ingredients (API) Manufacturing
Final Dosage Form (FDF) Manufacturing Packaging
Medical Device Contract Manufacturing Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Outsourcing Design
Device Manufacturing
Material Process Services
Electronic Manufacturing Services
Finished Products
Final Goods Assembly

6. Global Healthcare CMO Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific (Patheon)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Recipharm AB
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siegfried Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aenova Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Piramal Pharma Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Evonik Industries AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Famar Health Care Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Consort Medical plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer CentreOne
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter BioPharma Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jubilant HollisterStier
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vetter Pharma International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ajinomoto Bio-Pharma Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fareva Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies

8. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. References and Research Methodology

References
Research Methodology
About us and Sales Contact